Olympus Corp. Stock Hits Day Low Amid Price Pressure, Closes at JPY 1,870.50

Olympus Corp., a prominent player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline of 3.47% on October 8, 2025. The stock reached an intraday low of JPY 1,870.50, reflecting ongoing volatility in its performance metrics.
Over the past year, Olympus Corp. has faced significant challenges, with a return of -32.97%, contrasting sharply with the Japan Nikkei 225's gain of 21.91% during the same period. Year-to-date, the stock has also underperformed, showing a decline of 20.8% compared to the index's increase of 20.19%.

Despite these short-term setbacks, Olympus Corp. has demonstrated strong long-term fundamentals, highlighted by an average Return on Equity (ROE) of 18.96% and a low Debt to EBITDA ratio of 0.43 times. The company has reported positive results for the last three consecutive quarters, with operating cash flow peaking at JPY 152,003 million.

While the stock is currently trading at a premium with a Price to Book ratio of 2.91, it continues to show resilience in its operational performance, with a healthy growth rate in operating profit.